Back to Clinical Trials

Brief Title: New Anti-cancer Drug Eribulin With or Without Chemotherapy Against the Usual Chemotherapy Alone in Metastatic Urothelial Cancer

A Phase III Randomized Trial of Eribulin (NSC #707389) With Gemcitabine Versus Standard of Care (Physician's Choice) for Treatment of Metastatic Urothelial Carcinoma Refractory to, or Ineligible for, Anti PD1/PDL1 Therapy

INTRODUCTION

  • Org Study ID: NCI-2020-07651
  • Secondary ID: N/A
  • NCT ID: NCT04579224
  • Sponsor: National Cancer Institute (NCI)

BRIEF SUMMARY

This phase III trial compares the usual chemotherapy treatment to eribulin plus gemcitabine in treating patients with urothelial cancer that has spread to other places in the body (metastatic). Chemotherapy drugs, such as eribulin, gemcitabine, docetaxel, paclitaxel, and sacituzumab govitecan work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. This trial aims to see whether adding eribulin to standard of care chemotherapy may work better in treating patients with metastatic urothelial cancer.

DETAILED DESCRIPTION

PRIMARY OBJECTIVES:

I. To compare overall survival in participants with metastatic urothelial carcinoma (mUC) who are randomized to standard treatment versus eribulin plus gemcitabine hydrochloride (gemcitabine).

SECONDARY OBJECTIVES:

I. To compare progression-free survival (PFS) in the standard treatment arm to the experimental treatment arm in this population.

II. To compare Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 overall response rate (ORR), both confirmed and unconfirmed, complete and partial responses (CR and PR), in the standard treatment arm to the experimental treatment arm in the subset of participants with measurable disease in this population.

III. To compare duration of response (DOR) in the standard treatment arm to the experimental treatment arm in the subset of participants with measurable disease in this population.

IV. To compare disease control rate (DCR) in the standard treatment arm to the experimental treatment arm in the subset of participants with measurable disease in this population.

BANKING OBJECTIVE:

I. To bank specimens for future correlative studies.

OUTLINE: Patients are randomized to 1 of 3 arms.

ARM I: Patients receive 1 of the 4 standard of care chemotherapy regimens based on treating investigator's choice: Choice A: Patients receive docetaxel intravenously (IV) on day 1. Cycles repeat every 21 days in the absence of disease progression or unacceptable toxicity. Choice B: Patients receive gemcitabine IV on days 1, 8, and 15. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity. Choice C: Patients receive paclitaxel IV on days 1, 8, and 15. Cycles repeat every 21 days in the absence of disease progression or unacceptable toxicity. Choice D: Patients receive sacituzumab govitecan IV on days 1 and 8. Cycles repeat every 21 days in the absence of disease progression or unacceptable toxicity.

ARM II: Patients receive eribulin IV over 2-5 minutes on days 1 and 8. Cycles repeat every 21 days in the absence of disease progression or unacceptable toxicity. (CLOSED TO ACCRUAL)

ARM III: Patients receive eribulin IV over 2-5 minutes and gemcitabine IV on days 1 and 8. Cycles repeat every 21 days in the absence of disease progression or unacceptable toxicity.

All patients undergo computed tomography (CT), magnetic resonance imaging (MRI) and bone scan throughout the trial. Patients also undergo blood and urine sample collection on the trial.

After completion of study treatment, patients are followed up every 6 months for 2 years from the date of registration, then every 12 months until death or 3 years from the date of registration

  • Overall Status
    Recruiting
  • Start Date
    June 28, 2021
  • Phase
    Phase 3
  • Study Type
    Interventional

PRIMARY OUTCOMES

Primary Outcome 1 - Measure:

Primary Outcome 1 - Timeframe: N/A

CONDITION

  • Metastatic Bladder Urothelial Carcinoma
  • Metastatic Renal Pelvis Urothelial Carcinoma
  • Metastatic Ureter Urothelial Carcinoma
  • Metastatic Urethral Urothelial Carcinoma
  • Metastatic Urothelial Carcinoma
  • Refractory Bladder Urothelial Carcinoma
  • Refractory Renal Pelvis Urothelial Carcinoma
  • Refractory Ureter Urothelial Carcinoma
  • Refractory Urethral Urothelial Carcinoma
  • Refractory Urothelial Carcinoma
  • Stage IV Bladder Cancer AJCC v8
  • Stage IV Renal Pelvis and Ureter Cancer AJCC v8
  • Stage IV Renal Pelvis Cancer AJCC v8
  • Stage IV Ureter Cancer AJCC v8
  • Stage IV Urethral Cancer AJCC v8
  • Stage IVA Bladder Cancer AJCC v8
  • Stage IVB Bladder Cancer AJCC v8

ELIGIBILITY

Inclusion Criteria:
* Participant must have predominant histologically and cytologically proven urothelial carcinoma in a metastatic site

- * Participant must have evidence of metastatic urothelial carcinoma based on CT or MRI within 28 days prior to registration

- * Participant must have had progression of disease following prior therapy at the discretion of the treating investigator

- * Participants must not require immediate central nervous system (CNS)-specific treatment, in the opinion of the treating investigator if they have active brain metastases (defined as new or progressive brain metastases) or leptomeningeal disease

- * Participant must have had prior systemic therapy in metastatic setting that:
* Included enfortumab vedotin

- * Included a PD1/PDL1 antibody
* NOTE: Under the discretion of the treating physician, participants who are not candidates for PD1/PDL1 antibody systemic therapy are allowed

- * Any systemic therapy provided in adjuvant, neoadjuvant, or chemoradiation settings for urothelial carcinoma can be considered to be in metastatic setting, if the last day of treatment was within 12 months prior to the diagnosis of metastatic disease

- * Participant must have completed any planned surgery or radiation therapy prior to registration

- * Participant must not have unresolved toxicities from prior surgeries or radiation therapy > grade 1 at the time of registration

- * Participant must be ≥ 18 years of age

- * Participant must have Zubrod performance status 0-2

- * Participant must have history and physical examination within 28 days prior to registration

- * Participant must have complete blood count (CBC), complete metabolic panel including liver function tests, and lactate dehydrogenase (LDH) obtained with 28 days prior to registration

- * Participant must have adequate kidney function as evidenced by measured or calculated creatinine clearance >= 20 mL/min within 28 days prior to registration

- * Participant must have adequate hepatic function documented by either aspartate aminotransferase (AST) or alanine aminotransferase (ALT) =< 3 x institutional upper limit of normal (IULN) within 28 days prior to registration. If both AST and ALT are performed, both must be =< 3 x IULN. For participants with liver metastases, AST or ALT must be =< 5 x IULN - * Participant must be on effective anti-retroviral therapy and have undetectable viral load at their most recent viral load test and within 6 months prior to registration if they are known to have human immunodeficiency virus (HIV)-infection - * Participants must have undetectable hepatitis B virus (HBV) viral load within 28 days prior to registration if participant has known chronic hepatitis B virus (HBV) infection - * Participants with a known history of hepatitis C virus (HCV) infection must have an undetectable HCV viral load within 28 days prior to registration - * Participants may have a prior or concurrent malignancy provided the natural history or treatment does not have the potential to interfere with the safety or efficacy assessment of the investigational regimen per the opinion of the treating investigator - * Participants must not be planning to take strong or moderate CYP3A or CYP2C8 inhibitors or inducers if randomized to Arm 1 and standard of care (SOC) regimen chosen is paclitaxel or docetaxel. Participants receiving strong or moderate CYP3A- or CYP2C8 inducers must discontinue use at least 2 weeks prior to randomization - * Participant must not have a known history of corrected QT (QTc) prolongation - * Participants must not be pregnant or nursing due to the risk of harm to a fetus or nursing infant. Women and men of reproductive potential must have agreed to use an effective contraceptive method for the course of the study and 6 months (females) or 3.5 months (males) after the last dose. A woman is considered to be of "reproductive potential" if she has had menses at any time in the preceding 12 consecutive months. In addition to routine contraceptive methods, "effective contraception" also includes heterosexual celibacy and surgery intended to prevent pregnancy (or with a side-effect of pregnancy prevention) defined as a hysterectomy, bilateral oophorectomy or bilateral tubal ligation. However, if at any point a previously celibate participant chooses to become heterosexually active during the time period for use of contraceptive measures outlined in the protocol, he/she is responsible for beginning contraceptive measures - * Participants must be informed of the investigational nature of this study and must sign and give written informed consent in accordance with institutional and federal guidelines

Gender: All

Minimum Age: 18 Years

Maximum Age: N/A

Healthy Volunteers: No

OFFICIAL INFORMATION

Name: Sarmad Sadeghi

Role: Principal Investigator

Affiliation: SWOG Cancer Research Network

Overall Contact

Name: N/A

Phone: N/A

Email: N/A

LOCATION

Facility Status Contact
Facility: Kingman Regional Medical Center
Kingman, Arizona 86401
United States
Status: Recruiting Contact: Contact
Site Public Contact
702-384-0013
research@sncrf.org

Principal Investigator
John A. Ellerton

Facility: Cancer Center at Saint Joseph's
Phoenix, Arizona 85004
United States
Status: Recruiting Contact: Contact
Site Public Contact
720-874-1881
ResearchInstituteInquiries@CommonSpirit.org

Principal Investigator
Shahzad Siddique

Facility: PCR Oncology
Arroyo Grande, California 93420
United States
Status: Recruiting Contact: Contact
Site Public Contact
702-384-0013
research@sncrf.org

Principal Investigator
John A. Ellerton

Facility: Keck Medicine of USC Koreatown
Los Angeles, California 90020
United States
Status: Recruiting Contact: Contact
Site Public Contact
213-388-0908

Principal Investigator
Sarmad Sadeghi

Facility: Los Angeles General Medical Center
Los Angeles, California 90033
United States
Status: Recruiting Contact: Contact
Site Public Contact
323-865-0451
uscnorrisinfo@med.usc.edu

Principal Investigator
Sarmad Sadeghi

Facility: USC / Norris Comprehensive Cancer Center
Los Angeles, California 90033
United States
Status: Recruiting Contact: Contact
Site Public Contact
323-865-0451

Principal Investigator
Sarmad Sadeghi

Facility: Fremont - Rideout Cancer Center
Marysville, California 95901
United States
Status: Recruiting Contact: Contact
Site Public Contact
530-749-4400

Principal Investigator
Primo N. Lara

Facility: USC Norris Oncology/Hematology-Newport Beach
Newport Beach, California 92663
United States
Status: Recruiting Contact: Contact
Site Public Contact
323-865-0451

Principal Investigator
Sarmad Sadeghi

Facility: UC Irvine Health/Chao Family Comprehensive Cancer Center
Orange, California 92868
United States
Status: Recruiting Contact: Contact
Site Public Contact
877-827-8839
ucstudy@uci.edu

Principal Investigator
Nataliya Mar

Facility: University of California Davis Comprehensive Cancer Center
Sacramento, California 95817
United States
Status: Recruiting Contact: Contact
Site Public Contact
916-734-3089

Principal Investigator
Primo N. Lara

Facility: UCHealth University of Colorado Hospital
Aurora, Colorado 80045
United States
Status: Recruiting Contact: Contact
Site Public Contact
720-848-0650

Principal Investigator
Elizabeth R. Kessler

Facility: Porter Adventist Hospital
Denver, Colorado 80210
United States
Status: Recruiting Contact: Contact
Site Public Contact
719-776-6550
ResearchTracking@Centura.Org

Principal Investigator
Mohammed Salhab

Facility: Poudre Valley Hospital
Fort Collins, Colorado 80524
United States
Status: Recruiting Contact: Contact
Site Public Contact
970-297-6150

Principal Investigator
Elizabeth R. Kessler

Facility: Cancer Care and Hematology-Fort Collins
Fort Collins, Colorado 80528
United States
Status: Recruiting Contact: Contact
Site Public Contact
protocols@swog.org

Principal Investigator
Elizabeth R. Kessler

Facility: UCHealth Greeley Hospital
Greeley, Colorado 80631
United States
Status: Recruiting Contact: Contact
Site Public Contact
protocols@swog.org

Principal Investigator
Elizabeth R. Kessler

Facility: UCHealth Highlands Ranch Hospital
Highlands Ranch, Colorado 80129
United States
Status: Recruiting Contact: Contact
Site Public Contact
720-848-0650

Principal Investigator
Elizabeth R. Kessler

Facility: Medical Center of the Rockies
Loveland, Colorado 80538
United States
Status: Recruiting Contact: Contact
Site Public Contact
970-203-7083

Principal Investigator
Elizabeth R. Kessler

Facility: Parker Adventist Hospital
Parker, Colorado 80138
United States
Status: Recruiting Contact: Contact
Site Public Contact
719-776-6550
ResearchTracking@Centura.Org

Principal Investigator
Mohammed Salhab

Facility: Smilow Cancer Hospital-Derby Care Center
Derby, Connecticut 06418
United States
Status: Recruiting Contact: Contact
Site Public Contact
203-785-5702
canceranswers@yale.edu

Principal Investigator
Matthew Austin

Facility: Smilow Cancer Hospital Care Center-Fairfield
Fairfield, Connecticut 06824
United States
Status: Recruiting Contact: Contact
Site Public Contact
203-785-5702
canceranswers@yale.edu

Principal Investigator
Matthew Austin

Facility: Smilow Cancer Hospital Care Center at Glastonbury
Glastonbury, Connecticut 06033
United States
Status: Recruiting Contact: Contact
Site Public Contact
203-785-5702
canceranswers@yale.edu

Principal Investigator
Matthew Austin

Facility: Smilow Cancer Hospital Care Center at Greenwich
Greenwich, Connecticut 06830
United States
Status: Recruiting Contact: Contact
Site Public Contact
203-785-5702
canceranswers@yale.edu

Principal Investigator
Matthew Austin

Facility: Smilow Cancer Hospital Care Center - Guilford
Guilford, Connecticut 06437
United States
Status: Recruiting Contact: Contact
Site Public Contact
203-785-5702
canceranswers@yale.edu

Principal Investigator
Matthew Austin

Facility: Smilow Cancer Hospital Care Center at Saint Francis
Hartford, Connecticut 06105
United States
Status: Recruiting Contact: Contact
Site Public Contact
203-785-5702
canceranswers@yale.edu

Principal Investigator
Matthew Austin

Facility: Yale University
New Haven, Connecticut 06520
United States
Status: Recruiting Contact: Contact
Site Public Contact
203-785-5702
canceranswers@yale.edu

Principal Investigator
Matthew Austin

Facility: Yale-New Haven Hospital North Haven Medical Center
North Haven, Connecticut 06473
United States
Status: Recruiting Contact: Contact
Site Public Contact
203-785-5702
canceranswers@yale.edu

Principal Investigator
Matthew Austin

Facility: Smilow Cancer Hospital Care Center at Long Ridge
Stamford, Connecticut 06902
United States
Status: Recruiting Contact: Contact
Site Public Contact
203-785-5702
canceranswers@yale.edu

Principal Investigator
Matthew Austin

Facility: Smilow Cancer Hospital-Torrington Care Center
Torrington, Connecticut 06790
United States
Status: Recruiting Contact: Contact
Site Public Contact
203-785-5702
canceranswers@yale.edu

Principal Investigator
Matthew Austin

Facility: Smilow Cancer Hospital Care Center-Trumbull
Trumbull, Connecticut 06611
United States
Status: Recruiting Contact: Contact
Site Public Contact
203-785-5702
canceranswers@yale.edu

Principal Investigator
Matthew Austin

Facility: Smilow Cancer Hospital-Waterbury Care Center
Waterbury, Connecticut 06708
United States
Status: Recruiting Contact: Contact
Site Public Contact
203-785-5702
canceranswers@yale.edu

Principal Investigator
Matthew Austin

Facility: Smilow Cancer Hospital Care Center - Waterford
Waterford, Connecticut 06385
United States
Status: Recruiting Contact: Contact
Site Public Contact
203-785-5702
canceranswers@yale.edu

Principal Investigator
Matthew Austin

Facility: Holy Cross Hospital
Fort Lauderdale, Florida 33308
United States
Status: Recruiting Contact: Contact
Site Public Contact
eileen.georgi@holy-cross.com

Principal Investigator
Christopher M. Reynolds

Facility: Saint Alphonsus Cancer Care Center-Boise
Boise, Idaho 83706
United States
Status: Recruiting Contact: Contact
Site Public Contact
734-712-3671
stephanie.couch@stjoeshealth.org

Principal Investigator
John M. Schallenkamp

Facility: Saint Alphonsus Cancer Care Center-Caldwell
Caldwell, Idaho 83605
United States
Status: Recruiting Contact: Contact
Site Public Contact
734-712-3671
stephanie.couch@stjoeshealth.org

Principal Investigator
John M. Schallenkamp

Facility: Kootenai Health - Coeur d'Alene
Coeur d'Alene, Idaho 83814
United States
Status: Recruiting Contact: Contact
Site Public Contact
406-969-6060
mccinfo@mtcancer.org

Principal Investigator
John M. Schallenkamp

Facility: Saint Alphonsus Cancer Care Center-Nampa
Nampa, Idaho 83687
United States
Status: Recruiting Contact: Contact
Site Public Contact
406-969-6060
mccinfo@mtcancer.org

Principal Investigator
John M. Schallenkamp

Facility: Kootenai Clinic Cancer Services - Post Falls
Post Falls, Idaho 83854
United States
Status: Recruiting Contact: Contact
Site Public Contact
406-969-6060
mccinfo@mtcancer.org

Principal Investigator
John M. Schallenkamp

Facility: Kootenai Clinic Cancer Services - Sandpoint
Sandpoint, Idaho 83864
United States
Status: Recruiting Contact: Contact
Site Public Contact
406-969-6060
mccinfo@mtcancer.org

Principal Investigator
John M. Schallenkamp

Facility: Northwestern University
Chicago, Illinois 60611
United States
Status: Recruiting Contact: Contact
Site Public Contact
312-695-1301
cancer@northwestern.edu

Principal Investigator
Maha H. Hussain

Facility: Carle at The Riverfront
Danville, Illinois 61832
United States
Status: Recruiting Contact: Contact
Site Public Contact
800-446-5532
Research@Carle.com

Principal Investigator
Prem Sobti

Facility: Cancer Care Specialists of Illinois - Decatur
Decatur, Illinois 62526
United States
Status: Recruiting Contact: Contact
Site Public Contact
217-876-4762
morganthaler.jodi@mhsil.com

Principal Investigator
Bryan A. Faller

Facility: Decatur Memorial Hospital
Decatur, Illinois 62526
United States
Status: Recruiting Contact: Contact
Site Public Contact
217-876-4762
morganthaler.jodi@mhsil.com

Principal Investigator
Bryan A. Faller

Facility: Northwestern Medicine Cancer Center Kishwaukee
DeKalb, Illinois 60115
United States
Status: Recruiting Contact: Contact
Site Public Contact
630-352-5360
Donald.Smith3@nm.org

Principal Investigator
Maha H. Hussain

Facility: Carle Physician Group-Effingham
Effingham, Illinois 62401
United States
Status: Recruiting Contact: Contact
Site Public Contact
800-446-5532
Research@carle.com

Principal Investigator
Prem Sobti

Facility: Crossroads Cancer Center
Effingham, Illinois 62401
United States
Status: Recruiting Contact: Contact
Site Public Contact
217-876-4762
morganthaler.jodi@mhsil.com

Principal Investigator
Bryan A. Faller

Facility: Northwestern Medicine Cancer Center Delnor
Geneva, Illinois 60134
United States
Status: Recruiting Contact: Contact
Site Public Contact
630-352-5360
Donald.Smith3@nm.org

Principal Investigator
Maha H. Hussain

Facility: Northwestern Medicine Lake Forest Hospital
Lake Forest, Illinois 60045
United States
Status: Recruiting Contact: Contact
Site Public Contact
cancertrials@northwestern.edu

Principal Investigator
Maha H. Hussain

Facility: Carle Physician Group-Mattoon/Charleston
Mattoon, Illinois 61938
United States
Status: Recruiting Contact: Contact
Site Public Contact
800-446-5532
Research@carle.com

Principal Investigator
Prem Sobti

Facility: Loyola University Medical Center
Maywood, Illinois 60153
United States
Status: Recruiting Contact: Contact
Site Public Contact
708-226-4357

Principal Investigator
Joseph I. Clark

Facility: Marjorie Weinberg Cancer Center at Loyola-Gottlieb
Melrose Park, Illinois 60160
United States
Status: Recruiting Contact: Contact
Site Public Contact
708-450-4554

Principal Investigator
Joseph I. Clark

Facility: Cancer Care Center of O'Fallon
O'Fallon, Illinois 62269
United States
Status: Recruiting Contact: Contact
Site Public Contact
217-876-4762
morganthaler.jodi@mhsil.com

Principal Investigator
Bryan A. Faller

Facility: Southern Illinois University School of Medicine
Springfield, Illinois 62702
United States
Status: Recruiting Contact: Contact
Site Public Contact
217-545-7929

Principal Investigator
Bryan A. Faller

Facility: Springfield Clinic
Springfield, Illinois 62702
United States
Status: Recruiting Contact: Contact
Site Public Contact
800-444-7541

Principal Investigator
Bryan A. Faller

Facility: Carle Cancer Center
Urbana, Illinois 61801
United States
Status: Recruiting Contact: Contact
Site Public Contact
800-446-5532
Research@carle.com

Principal Investigator
Prem Sobti

Facility: Northwestern Medicine Cancer Center Warrenville
Warrenville, Illinois 60555
United States
Status: Recruiting Contact: Contact
Site Public Contact
630-352-5360
Donald.Smith3@nm.org

Principal Investigator
Maha H. Hussain

Facility: Mary Greeley Medical Center
Ames, Iowa 50010
United States
Status: Recruiting Contact: Contact
Site Public Contact
515-956-4132

Principal Investigator
Joseph J. Merchant

Facility: McFarland Clinic - Ames
Ames, Iowa 50010
United States
Status: Recruiting Contact: Contact
Site Public Contact
515-239-4734
ksoder@mcfarlandclinic.com

Principal Investigator
Joseph J. Merchant

Facility: Mission Cancer and Blood - Ankeny
Ankeny, Iowa 50023
United States
Status: Recruiting Contact: Contact
Site Public Contact
515-282-2921

Principal Investigator
Richard L. Deming

Facility: McFarland Clinic - Boone
Boone, Iowa 50036
United States
Status: Recruiting Contact: Contact
Site Public Contact
515-956-4132

Principal Investigator
Joseph J. Merchant

Facility: Saint Anthony Regional Hospital
Carroll, Iowa 51401
United States
Status: Recruiting Contact: Contact
Site Public Contact
515-689-7658
sbenson@iora.org

Principal Investigator
Seema Harichand-Herdt

Facility: Iowa Methodist Medical Center
Des Moines, Iowa 50309
United States
Status: Recruiting Contact: Contact
Site Public Contact
515-241-6727

Principal Investigator
Seema Harichand-Herdt

Facility: Mission Cancer and Blood - Des Moines
Des Moines, Iowa 50309
United States
Status: Recruiting Contact: Contact
Site Public Contact
515-241-3305

Principal Investigator
Seema Harichand-Herdt

Facility: Broadlawns Medical Center
Des Moines, Iowa 50314
United States
Status: Recruiting Contact: Contact
Site Public Contact
515-282-2200

Principal Investigator
Seema Harichand-Herdt

Facility: McFarland Clinic - Trinity Cancer Center
Fort Dodge, Iowa 50501
United States
Status: Recruiting Contact: Contact
Site Public Contact
515-956-4132

Principal Investigator
Joseph J. Merchant

Facility: McFarland Clinic - Jefferson
Jefferson, Iowa 50129
United States
Status: Recruiting Contact: Contact
Site Public Contact
515-956-4132

Principal Investigator
Joseph J. Merchant

Facility: McFarland Clinic - Marshalltown
Marshalltown, Iowa 50158
United States
Status: Recruiting Contact: Contact
Site Public Contact
515-956-4132

Principal Investigator
Joseph J. Merchant

Facility: HaysMed
Hays, Kansas 67601
United States
Status: Recruiting Contact: Contact
Site Public Contact
785-623-5774

Principal Investigator
Saqib Abbasi

Facility: University of Kansas Cancer Center
Kansas City, Kansas 66160
United States
Status: Recruiting Contact: Contact
Site Public Contact
913-588-3671
KUCC_Navigation@kumc.edu

Principal Investigator
Saqib Abbasi

Facility: Lawrence Memorial Hospital
Lawrence, Kansas 66044
United States
Status: Recruiting Contact: Contact
Site Public Contact
785-505-2800
Stephanie.Norris@LMH.ORG

Principal Investigator
Saqib Abbasi

Facility: Olathe Health Cancer Center
Olathe, Kansas 66061
United States
Status: Recruiting Contact: Contact
Site Public Contact
913-355-8000
Jeni.wakefield@olathehealth.org

Principal Investigator
Saqib Abbasi

Facility: University of Kansas Cancer Center-Overland Park
Overland Park, Kansas 66210
United States
Status: Recruiting Contact: Contact
Site Public Contact
913-588-3671
KUCC_Navigation@kumc.edu

Principal Investigator
Saqib Abbasi

Facility: University of Kansas Hospital-Indian Creek Campus
Overland Park, Kansas 66211
United States
Status: Recruiting Contact: Contact
Site Public Contact
913-588-3671
KUCC_Navigation@kumc.edu

Principal Investigator
Saqib Abbasi

Facility: Salina Regional Health Center
Salina, Kansas 67401
United States
Status: Recruiting Contact: Contact
Site Public Contact
785-452-7038
mleepers@srhc.com

Principal Investigator
Saqib Abbasi

Facility: University of Kansas Health System Saint Francis Campus
Topeka, Kansas 66606
United States
Status: Recruiting Contact: Contact
Site Public Contact
785-295-8000

Principal Investigator
Saqib Abbasi

Facility: University of Kansas Hospital-Westwood Cancer Center
Westwood, Kansas 66205
United States
Status: Recruiting Contact: Contact
Site Public Contact
913-588-3671
KUCC_Navigation@kumc.edu

Principal Investigator
Saqib Abbasi

Facility: University of Kentucky/Markey Cancer Center
Lexington, Kentucky 40536
United States
Status: Recruiting Contact: Contact
Site Public Contact
859-257-3379

Principal Investigator
Zin W. Myint

Facility: Trinity Health Saint Joseph Mercy Hospital Ann Arbor
Ann Arbor, Michigan 48106
United States
Status: Recruiting Contact: Contact
Site Public Contact
734-712-7251
MCRCwebsitecontactform@stjoeshealth.org

Principal Investigator
Christopher M. Reynolds

Facility: Bronson Battle Creek
Battle Creek, Michigan 49017
United States
Status: Recruiting Contact: Contact
Site Public Contact
616-391-1230
crcwm-regulatory@crcwm.org

Principal Investigator
Kathleen J. Yost

Facility: Trinity Health IHA Medical Group Hematology Oncology - Brighton
Brighton, Michigan 48114
United States
Status: Recruiting Contact: Contact
Site Public Contact
734-712-7251
MCRCwebsitecontactform@stjoeshealth.org

Principal Investigator
Christopher M. Reynolds

Facility: Trinity Health Medical Center - Brighton
Brighton, Michigan 48114
United States
Status: Recruiting Contact: Contact
Site Public Contact
734-712-7251
MCRCwebsitecontactform@stjoeshealth.org

Principal Investigator
Christopher M. Reynolds

Facility: Trinity Health IHA Medical Group Hematology Oncology - Canton
Canton, Michigan 48188
United States
Status: Recruiting Contact: Contact
Site Public Contact
734-712-7251
MCRCwebsitecontactform@stjoeshealth.org

Principal Investigator
Christopher M. Reynolds

Facility: Trinity Health Medical Center - Canton
Canton, Michigan 48188
United States
Status: Recruiting Contact: Contact
Site Public Contact
734-712-7251
MCRCwebsitecontactform@stjoeshealth.org

Principal Investigator
Christopher M. Reynolds

Facility: Chelsea Hospital
Chelsea, Michigan 48118
United States
Status: Recruiting Contact: Contact
Site Public Contact
734-712-7251
MCRCwebsitecontactform@stjoeshealth.org

Principal Investigator
Christopher M. Reynolds

Facility: Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital
Chelsea, Michigan 48118
United States
Status: Recruiting Contact: Contact
Site Public Contact
734-712-7251
MCRCwebsitecontactform@stjoeshealth.org

Principal Investigator
Christopher M. Reynolds

Facility: Hematology Oncology Consultants-Clarkston
Clarkston, Michigan 48346
United States
Status: Recruiting Contact: Contact
Site Public Contact
734-712-7251
MCRCwebsitecontactform@stjoeshealth.org

Principal Investigator
Christopher M. Reynolds

Facility: Newland Medical Associates-Clarkston
Clarkston, Michigan 48346
United States
Status: Recruiting Contact: Contact
Site Public Contact
734-712-7251
MCRCwebsitecontactform@stjoeshealth.org

Principal Investigator
Christopher M. Reynolds

Facility: Henry Ford Macomb Hospital-Clinton Township
Clinton Township, Michigan 48038
United States
Status: Recruiting Contact: Contact
Site Public Contact
313-916-3721
CTOResearch@hfhs.org

Principal Investigator
Haythem Y. Ali

Facility: Henry Ford Hospital
Detroit, Michigan 48202
United States
Status: Recruiting Contact: Contact
Site Public Contact
313-916-3721
CTOResearch@hfhs.org

Principal Investigator
Haythem Y. Ali

Facility: Ascension Saint John Hospital
Detroit, Michigan 48236
United States
Status: Recruiting Contact: Contact
Site Public Contact
313-343-3166
karen.forman@ascension.org

Principal Investigator
Christopher M. Reynolds

Facility: Great Lakes Cancer Management Specialists-Doctors Park
East China Township, Michigan 48054
United States
Status: Recruiting Contact: Contact
Site Public Contact
313-343-3166
karen.forman@ascension.org

Principal Investigator
Christopher M. Reynolds

Facility: Genesee Cancer and Blood Disease Treatment Center
Flint, Michigan 48503
United States
Status: Recruiting Contact: Contact
Site Public Contact
810-762-8038
wstrong@ghci.org

Principal Investigator
Christopher M. Reynolds

Facility: Genesee Hematology Oncology PC
Flint, Michigan 48503
United States
Status: Recruiting Contact: Contact
Site Public Contact
810-762-8038
wstrong@ghci.org

Principal Investigator
Christopher M. Reynolds

Facility: Genesys Hurley Cancer Institute
Flint, Michigan 48503
United States
Status: Recruiting Contact: Contact
Site Public Contact
810-762-8038
wstrong@ghci.org

Principal Investigator
Christopher M. Reynolds

Facility: Hurley Medical Center
Flint, Michigan 48503
United States
Status: Recruiting Contact: Contact
Site Public Contact
810-762-8038
wstrong@ghci.org

Principal Investigator
Christopher M. Reynolds

Facility: Corewell Health Grand Rapids Hospitals - Butterworth Hospital
Grand Rapids, Michigan 49503
United States
Status: Recruiting Contact: Contact
Site Public Contact
616-391-1230
crcwm-regulatory@crcwm.org

Principal Investigator
Kathleen J. Yost

Facility: Academic Hematology Oncology Specialists
Grosse Pointe Woods, Michigan 48236
United States
Status: Recruiting Contact: Contact
Site Public Contact
313-343-3166
karen.forman@ascension.org

Principal Investigator
Christopher M. Reynolds

Facility: Great Lakes Cancer Management Specialists-Van Elslander Cancer Center
Grosse Pointe Woods, Michigan 48236
United States
Status: Recruiting Contact: Contact
Site Public Contact
313-343-3166
karen.forman@ascension.org

Principal Investigator
Christopher M. Reynolds

Facility: Bronson Methodist Hospital
Kalamazoo, Michigan 49007
United States
Status: Recruiting Contact: Contact
Site Public Contact
616-391-1230
crcwm-regulatory@crcwm.org

Principal Investigator
Kathleen J. Yost

Facility: West Michigan Cancer Center
Kalamazoo, Michigan 49007
United States
Status: Recruiting Contact: Contact
Site Public Contact
616-391-1230
crcwm-regulatory@crcwm.org

Principal Investigator
Kathleen J. Yost

Facility: Ascension Borgess Cancer Center
Kalamazoo, Michigan 49009
United States
Status: Recruiting Contact: Contact
Site Public Contact
616-391-1230
crcwm-regulatory@crcwm.org

Principal Investigator
Kathleen J. Yost

Facility: Trinity Health Saint Mary Mercy Livonia Hospital
Livonia, Michigan 48154
United States
Status: Recruiting Contact: Contact
Site Public Contact
734-712-7251
MCRCwebsitecontactform@stjoeshealth.org

Principal Investigator
Christopher M. Reynolds

Facility: Great Lakes Cancer Management Specialists-Macomb Medical Campus
Macomb, Michigan 48044
United States
Status: Recruiting Contact: Contact
Site Public Contact
313-343-3166
karen.forman@ascension.org

Principal Investigator
Christopher M. Reynolds

Facility: Michigan Healthcare Professionals Pontiac
Pontiac, Michigan 48341
United States
Status: Recruiting Contact: Contact
Site Public Contact
248-858-6215
Emily.Crofts@trinity-health.org

Principal Investigator
Christopher M. Reynolds

Facility: Newland Medical Associates-Pontiac
Pontiac, Michigan 48341
United States
Status: Recruiting Contact: Contact
Site Public Contact
734-712-7251
MCRCwebsitecontactform@stjoeshealth.org

Principal Investigator
Christopher M. Reynolds

Facility: Trinity Health Saint Joseph Mercy Oakland Hospital
Pontiac, Michigan 48341
United States
Status: Recruiting Contact: Contact
Site Public Contact
734-712-7251
MCRCwebsitecontactform@stjoeshealth.org

Principal Investigator
Christopher M. Reynolds

Facility: Ascension Saint Mary's Hospital
Saginaw, Michigan 48601
United States
Status: Recruiting Contact: Contact
Site Public Contact
989-907-8411
lori.srebinski@ascension.org

Principal Investigator
Christopher M. Reynolds

Facility: Oncology Hematology Associates of Saginaw Valley PC
Saginaw, Michigan 48604
United States
Status: Recruiting Contact: Contact
Site Public Contact
989-907-8411
lori.srebinski@ascension.org

Principal Investigator
Christopher M. Reynolds

Facility: Bhadresh Nayak MD PC-Sterling Heights
Sterling Heights, Michigan 48312
United States
Status: Recruiting Contact: Contact
Site Public Contact
313-343-3166
karen.forman@ascension.org

Principal Investigator
Christopher M. Reynolds

Facility: Ascension Saint Joseph Hospital
Tawas City, Michigan 48764
United States
Status: Recruiting Contact: Contact
Site Public Contact
989-907-8411
lori.srebinski@ascension.org

Principal Investigator
Christopher M. Reynolds

Facility: Munson Medical Center
Traverse City, Michigan 49684
United States
Status: Recruiting Contact: Contact
Site Public Contact
616-391-1230
crcwm-regulatory@crcwm.org

Principal Investigator
Kathleen J. Yost

Facility: Advanced Breast Care Center PLLC
Warren, Michigan 48088
United States
Status: Recruiting Contact: Contact
Site Public Contact
313-343-3166
karen.forman@ascension.org

Principal Investigator
Christopher M. Reynolds

Facility: Great Lakes Cancer Management Specialists-Macomb Professional Building
Warren, Michigan 48093
United States
Status: Recruiting Contact: Contact
Site Public Contact
313-343-3166
karen.forman@ascension.org

Principal Investigator
Christopher M. Reynolds

Facility: Michigan Breast Specialists-Warren
Warren, Michigan 48093
United States
Status: Recruiting Contact: Contact
Site Public Contact
313-343-3166
karen.forman@ascension.org

Principal Investigator
Christopher M. Reynolds

Facility: Saint John Macomb-Oakland Hospital
Warren, Michigan 48093
United States
Status: Recruiting Contact: Contact
Site Public Contact
313-343-3166
karen.forman@ascension.org

Principal Investigator
Christopher M. Reynolds

Facility: Henry Ford West Bloomfield Hospital
West Bloomfield, Michigan 48322
United States
Status: Recruiting Contact: Contact
Site Public Contact
313-916-3721
CTOResearch@hfhs.org

Principal Investigator
Haythem Y. Ali

Facility: Saint Mary's Oncology/Hematology Associates of West Branch
West Branch, Michigan 48661
United States
Status: Recruiting Contact: Contact
Site Public Contact
989-907-8411
lori.srebinski@ascension.org

Principal Investigator
Christopher M. Reynolds

Facility: University of Michigan Health - West
Wyoming, Michigan 49519
United States
Status: Recruiting Contact: Contact
Site Public Contact
616-391-1230
crcwm-regulatory@crcwm.org

Principal Investigator
Kathleen J. Yost

Facility: Huron Gastroenterology PC
Ypsilanti, Michigan 48106
United States
Status: Recruiting Contact: Contact
Site Public Contact
734-712-7251
MCRCwebsitecontactform@stjoeshealth.org

Principal Investigator
Christopher M. Reynolds

Facility: Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus
Ypsilanti, Michigan 48197
United States
Status: Recruiting Contact: Contact
Site Public Contact
734-712-7251
MCRCwebsitecontactform@stjoeshealth.org

Principal Investigator
Christopher M. Reynolds

Facility: Sanford Joe Lueken Cancer Center
Bemidji, Minnesota 56601
United States
Status: Recruiting Contact: Contact
Site Public Contact
218-333-5000
OncologyClinicalTrialsFargo@sanfordhealth.org

Principal Investigator
Daniel Almquist

Facility: University of Mississippi Medical Center
Jackson, Mississippi 39216
United States
Status: Recruiting Contact: Contact
Site Public Contact
601-815-6700

Principal Investigator
John C. Henegan

Facility: Saint Francis Medical Center
Cape Girardeau, Missouri 63703
United States
Status: Recruiting Contact: Contact
Site Public Contact
573-334-2230
sfmc@sfmc.net

Principal Investigator
Bryan A. Faller

Facility: MU Health - University Hospital/Ellis Fischel Cancer Center
Columbia, Missouri 65212
United States
Status: Recruiting Contact: Contact
Site Public Contact
573-882-7440

Principal Investigator
Kushal Naha

Facility: Parkland Health Center - Farmington
Farmington, Missouri 63640
United States
Status: Recruiting Contact: Contact
Site Public Contact
314-996-5569

Principal Investigator
Bryan A. Faller

Facility: University Health Truman Medical Center
Kansas City, Missouri 64108
United States
Status: Recruiting Contact: Contact
Site Public Contact
816-404-4375

Principal Investigator
Saqib Abbasi

Facility: University of Kansas Cancer Center - North
Kansas City, Missouri 64154
United States
Status: Recruiting Contact: Contact
Site Public Contact
913-588-3671
KUCC_Navigation@kumc.edu

Principal Investigator
Saqib Abbasi

Facility: University of Kansas Cancer Center - Lee's Summit
Lee's Summit, Missouri 64064
United States
Status: Recruiting Contact: Contact
Site Public Contact
913-588-3671
KUCC_Navigation@kumc.edu

Principal Investigator
Saqib Abbasi

Facility: University of Kansas Cancer Center at North Kansas City Hospital
North Kansas City, Missouri 64116
United States
Status: Recruiting Contact: Contact
Site Public Contact
913-588-3671
KUCC_Navigation@kumc.edu

Principal Investigator
Saqib Abbasi

Facility: Missouri Baptist Medical Center
Saint Louis, Missouri 63131
United States
Status: Recruiting Contact: Contact
Site Public Contact
314-996-5569

Principal Investigator
Bryan A. Faller

Facility: Mercy Hospital Saint Louis
Saint Louis, Missouri 63141
United States
Status: Recruiting Contact: Contact
Site Public Contact
314-251-7066

Principal Investigator
Jay W. Carlson

Facility: Sainte Genevieve County Memorial Hospital
Sainte Genevieve, Missouri 63670
United States
Status: Recruiting Contact: Contact
Site Public Contact
314-996-5569

Principal Investigator
Bryan A. Faller

Facility: Missouri Baptist Sullivan Hospital
Sullivan, Missouri 63080
United States
Status: Recruiting Contact: Contact
Site Public Contact
314-996-5569

Principal Investigator
Bryan A. Faller

Facility: BJC Outpatient Center at Sunset Hills
Sunset Hills, Missouri 63127
United States
Status: Recruiting Contact: Contact
Site Public Contact
314-996-5569

Principal Investigator
Bryan A. Faller

Facility: Community Hospital of Anaconda
Anaconda, Montana 59711
United States
Status: Recruiting Contact: Contact
Site Public Contact
406-969-6060
mccinfo@mtcancer.org

Principal Investigator
John M. Schallenkamp

Facility: Billings Clinic Cancer Center
Billings, Montana 59101
United States
Status: Recruiting Contact: Contact
Site Public Contact
800-996-2663
research@billingsclinic.org

Principal Investigator
John M. Schallenkamp

Facility: Bozeman Health Deaconess Hospital
Bozeman, Montana 59715
United States
Status: Recruiting Contact: Contact
Site Public Contact
406-969-6060
mccinfo@mtcancer.org

Principal Investigator
John M. Schallenkamp

Facility: Benefis Sletten Cancer Institute
Great Falls, Montana 59405
United States
Status: Recruiting Contact: Contact
Site Public Contact
406-969-6060
mccinfo@mtcancer.org

Principal Investigator
John M. Schallenkamp

Facility: Kalispell Regional Medical Center
Kalispell, Montana 59901
United States
Status: Recruiting Contact: Contact
Site Public Contact
406-969-6060
mccinfo@mtcancer.org

Principal Investigator
John M. Schallenkamp

Facility: Community Medical Center
Missoula, Montana 59804
United States
Status: Recruiting Contact: Contact
Site Public Contact
406-969-6060
mccinfo@mtcancer.org

Principal Investigator
John M. Schallenkamp

Facility: OptumCare Cancer Care at Seven Hills
Henderson, Nevada 89052
United States
Status: Recruiting Contact: Contact
Site Public Contact
702-384-0013
research@sncrf.org

Principal Investigator
John A. Ellerton

Facility: OptumCare Cancer Care at Charleston
Las Vegas, Nevada 89102
United States
Status: Recruiting Contact: Contact
Site Public Contact
702-384-0013
research@sncrf.org

Principal Investigator
John A. Ellerton

Facility: OptumCare Cancer Care at Fort Apache
Las Vegas, Nevada 89148
United States
Status: Recruiting Contact: Contact
Site Public Contact
702-384-0013
research@sncrf.org

Principal Investigator
John A. Ellerton

Facility: Southeastern Medical Oncology Center-Clinton
Clinton, North Carolina 28328
United States
Status: Recruiting Contact: Contact
Site Public Contact
919-587-9084
jfields@cancersmoc.com

Principal Investigator
Samer S. Kasbari

Facility: Southeastern Medical Oncology Center-Goldsboro
Goldsboro, North Carolina 27534
United States
Status: Recruiting Contact: Contact
Site Public Contact
919-587-9084
jfields@cancersmoc.com

Principal Investigator
Samer S. Kasbari

Facility: Southeastern Medical Oncology Center-Jacksonville
Jacksonville, North Carolina 28546
United States
Status: Recruiting Contact: Contact
Site Public Contact
910-587-9084
jfields@cancersmoc.com

Principal Investigator
Samer S. Kasbari

Facility: Sanford Bismarck Medical Center
Bismarck, North Dakota 58501
United States
Status: Recruiting Contact: Contact
Site Public Contact
701-323-5760
OncologyClinicalTrialsFargo@sanfordhealth.org

Principal Investigator
Daniel Almquist

Facility: Sanford Broadway Medical Center
Fargo, North Dakota 58122
United States
Status: Recruiting Contact: Contact
Site Public Contact
701-323-5760
OncologyClinicalTrialsFargo@sanfordhealth.org

Principal Investigator
Daniel Almquist

Facility: Sanford Roger Maris Cancer Center
Fargo, North Dakota 58122
United States
Status: Recruiting Contact: Contact
Site Public Contact
701-234-6161
OncologyClinicalTrialsFargo@sanfordhealth.org

Principal Investigator
Daniel Almquist

Facility: UH Seidman Cancer Center at UH Avon Health Center
Avon, Ohio 44011
United States
Status: Recruiting Contact: Contact
Site Public Contact
800-641-2422

Principal Investigator
Jason Brown

Facility: UHHS-Chagrin Highlands Medical Center
Beachwood, Ohio 44122
United States
Status: Recruiting Contact: Contact
Site Public Contact
800-641-2422
CTUReferral@UHhospitals.org

Principal Investigator
Jason Brown

Facility: Case Western Reserve University
Cleveland, Ohio 44106
United States
Status: Recruiting Contact: Contact
Site Public Contact
800-641-2422
CTUReferral@UHhospitals.org

Principal Investigator
Jason Brown

Facility: UH Seidman Cancer Center at Lake Health Mentor Campus
Mentor, Ohio 44060
United States
Status: Recruiting Contact: Contact
Site Public Contact
800-641-2422
CTUReferral@UHhospitals.org

Principal Investigator
Jason Brown

Facility: University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma 73104
United States
Status: Recruiting Contact: Contact
Site Public Contact
405-271-8777
ou-clinical-trials@ouhsc.edu

Principal Investigator
Adanma Anji Ayanambakkam Attanathi

Facility: Saint Alphonsus Cancer Care Center-Ontario
Ontario, Oregon 97914
United States
Status: Recruiting Contact: Contact
Site Public Contact
406-969-6060
mccinfo@mtcancer.org

Principal Investigator
John M. Schallenkamp

Facility: Lehigh Valley Hospital-Cedar Crest
Allentown, Pennsylvania 18103
United States
Status: Recruiting Contact: Contact
Site Public Contact
610-402-9543
Morgan_M.Horton@lvhn.org

Principal Investigator
Christopher M. Reynolds

Facility: Lehigh Valley Hospital - Muhlenberg
Bethlehem, Pennsylvania 18017
United States
Status: Recruiting Contact: Contact
Site Public Contact
610-402-9543
Morgan_M.Horton@lvhn.org

Principal Investigator
Christopher M. Reynolds

Facility: Smilow Cancer Hospital Care Center - Westerly
Westerly, Rhode Island 02891
United States
Status: Recruiting Contact: Contact
Site Public Contact
203-785-5702
canceranswers@yale.edu

Principal Investigator
Matthew Austin

Facility: Medical University of South Carolina
Charleston, South Carolina 29425
United States
Status: Recruiting Contact: Contact
Site Public Contact
843-792-9321
hcc-clinical-trials@musc.edu

Principal Investigator
Theodore S. Gourdin

Facility: Sanford Cancer Center Oncology Clinic
Sioux Falls, South Dakota 57104
United States
Status: Recruiting Contact: Contact
Site Public Contact
605-312-3320
OncologyClinicTrialsSF@sanfordhealth.org

Principal Investigator
Daniel Almquist

Facility: Sanford USD Medical Center - Sioux Falls
Sioux Falls, South Dakota 57117-5134
United States
Status: Recruiting Contact: Contact
Site Public Contact
605-312-3320
OncologyClinicalTrialsSF@SanfordHealth.org

Principal Investigator
Daniel Almquist

Facility: The West Clinic - Wolf River
Germantown, Tennessee 38138
United States
Status: Recruiting Contact: Contact
Site Public Contact
901-683-0055
afletcher@westclinic.com

Principal Investigator
Daniel A. Vaena

Facility: Ballad Health Cancer Care - Kingsport
Kingsport, Tennessee 37660
United States
Status: Recruiting Contact: Contact
Site Public Contact
423-578-8538
Justin.reynolds@balladhealth.org

Principal Investigator
Asheesh Shipstone

Facility: UT Southwestern Simmons Cancer Center - RedBird
Dallas, Texas 75237
United States
Status: Recruiting Contact: Contact
Site Public Contact
214-648-7097
canceranswerline@utsouthwestern.edu

Principal Investigator
Suzanne M. Cole

Facility: UT Southwestern/Simmons Cancer Center-Dallas
Dallas, Texas 75390
United States
Status: Recruiting Contact: Contact
Site Public Contact
214-648-7097
canceranswerline@UTSouthwestern.edu

Principal Investigator
Suzanne M. Cole

Facility: UT Southwestern/Simmons Cancer Center-Fort Worth
Fort Worth, Texas 76104
United States
Status: Recruiting Contact: Contact
Site Public Contact
214-648-7097
canceranswerline@UTSouthwestern.edu

Principal Investigator
Suzanne M. Cole

Facility: UT Southwestern Clinical Center at Richardson/Plano
Richardson, Texas 75080
United States
Status: Recruiting Contact: Contact
Site Public Contact
972-669-7044
Suzanne.cole@utsouthwestern.edu

Principal Investigator
Suzanne M. Cole

Facility: Huntsman Cancer Institute/University of Utah
Salt Lake City, Utah 84112
United States
Status: Recruiting Contact: Contact
Site Public Contact
888-424-2100
cancerinfo@hci.utah.edu

Principal Investigator
Umang Swami

Facility: Wellmont Medical Associates-Bristol
Bristol, Virginia 24201
United States
Status: Recruiting Contact: Contact
Site Public Contact
423-578-8538
justin.reynolds@wellmont.org

Principal Investigator
Asheesh Shipstone

Facility: Southwest VA Regional Cancer Center
Norton, Virginia 24273
United States
Status: Recruiting Contact: Contact
Site Public Contact
423-578-8538
justin.reynolds@wellmont.org

Principal Investigator
Asheesh Shipstone

Facility: Harrison HealthPartners Hematology and Oncology-Bremerton
Bremerton, Washington 98310
United States
Status: Recruiting Contact: Contact
Site Public Contact
308-398-6518
clinicaltrials@sfmc-gi.org

Principal Investigator
Richard L. Deming

Facility: Edwards Comprehensive Cancer Center
Huntington, West Virginia 25701
United States
Status: Recruiting Contact: Contact
Site Public Contact
304-399-6566
Christina.Cole@chhi.org

Principal Investigator
Maria R. Tria Tirona

Facility: Marshfield Medical Center-EC Cancer Center
Eau Claire, Wisconsin 54701
United States
Status: Recruiting Contact: Contact
Site Public Contact
800-782-8581
oncology.clinical.trials@marshfieldresearch.org

Principal Investigator
Seth O. Fagbemi

Facility: Marshfield Medical Center-Marshfield
Marshfield, Wisconsin 54449
United States
Status: Recruiting Contact: Contact
Site Public Contact
800-782-8581
oncology.clinical.trials@marshfieldresearch.org

Principal Investigator
Seth O. Fagbemi

Facility: Marshfield Clinic-Minocqua Center
Minocqua, Wisconsin 54548
United States
Status: Recruiting Contact: Contact
Site Public Contact
800-782-8581
oncology.clinical.trials@marshfieldresearch.org

Principal Investigator
Seth O. Fagbemi

Facility: Cancer Center of Western Wisconsin
New Richmond, Wisconsin 54017
United States
Status: Recruiting Contact: Contact
Site Public Contact
952-993-1517
mmcorc@healthpartners.com

Principal Investigator
David M. King

Facility: Marshfield Medical Center-Rice Lake
Rice Lake, Wisconsin 54868
United States
Status: Recruiting Contact: Contact
Site Public Contact
800-782-8581
oncology.clinical.trials@marshfieldresearch.org

Principal Investigator
Seth O. Fagbemi

Facility: Marshfield Medical Center-River Region at Stevens Point
Stevens Point, Wisconsin 54482
United States
Status: Recruiting Contact: Contact
Site Public Contact
800-782-8581
oncology.clinical.trials@marshfieldresearch.org

Principal Investigator
Seth O. Fagbemi

Facility: Marshfield Medical Center - Weston
Weston, Wisconsin 54476
United States
Status: Recruiting Contact: Contact
Site Public Contact
800-782-8581
oncology.clinical.trials@marshfieldresearch.org

Principal Investigator
Seth O. Fagbemi